Methods and compositions for tissue regeneration

Details Methods and compositions for tissue regeneration Methods and compositions for tissue regeneration

2003-09-05

2008-11-11

Romeo, David (Department: 1647)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

C435S366000, C435S371000, C424S093100

Reexamination Certificate

active

07449333

ABSTRACT:
The present invention provides the use and composition of matter of angiogenic or other growth/cytokine factors expressed by mixtures of allogeneic human cell strains or lines of various types and stages of differentiation. Also provided are unencapsulated preparations (mixed with or applied to extracellular matrix material or synthetic biocompatible substances) for the purpose of temporary application to wounds or defects in the skin or other tissues for the restoration of blood supplying connective tissue to enable organ-specific cells to reestablish organ integrity as well as to inhibit excessive scar formation.

REFERENCES:
patent: 4837379 (1989-06-01), Weinberg
patent: 5290552 (1994-03-01), Sierra et al.
patent: 5855617 (1999-01-01), Orton
patent: 5863296 (1999-01-01), Orion
patent: 5891558 (1999-04-01), Bell et al.
patent: 5902608 (1999-05-01), Read et al.
patent: 5948429 (1999-09-01), Bell et al.
patent: 5968546 (1999-10-01), Baur et al.
patent: 6010887 (2000-01-01), Bridges et al.
patent: 6054122 (2000-04-01), MacPhee et al.
patent: 6479052 (2002-11-01), Marshall et al.
patent: 2002/0031500 (2002-03-01), MacLaughlin et al.
patent: 2002/0169105 (2002-11-01), Gestrelius et al.
patent: 2003/0064927 (2003-04-01), Gestrelius et al.
patent: 2003/0166274 (2003-09-01), Hewitt et al.
patent: 19949290 (2001-04-01), None
patent: 2132027 (1999-08-01), None
patent: 0 339 607 (1989-11-01), None
patent: WO 97/06835 (1997-02-01), None
patent: WO 99/15637 (1999-04-01), None
patent: WO 00/25838 (2000-05-01), None
patent: WO 00/32207 (2000-06-01), None
patent: WO 01/24842 (2001-04-01), None
patent: WO 02/072800 (2002-09-01), None
patent: WO 02/078721 (2002-10-01), None
Badiavas, et al., “Retrovirally Mediated Gene Transfer in a Skin Equivalent Model of Chronic Wounds”, J. Dermatol. Sci., 13:56-62 (1996).
Cooper, et al., “Use of a Composite Skin Graft Composed of Cultured Human Keratinocytes and Fibroblasts and a Collagen-GAG Matrix to Cover Full-Thickness Wounds on Athynic Mice”, Surgery, 109:198-207 (1991).
Currie, et al., “The Use of Fibrin Glue in Skin Grafts and Tissue-Engineered Skin Replacements: A Review”, Plast.—Reconstr. Surg., 108:1713-1726 (2001).
Davies Burns 10: 94-103 (1983).
Del Rio, et al., “A Preclinical Model for the Analysis of Genetically Modified Human Skin In Vivo”, Human Gene Therapy, 13:959-968 (2002).
Hunt and Goodson Current Surgical Diagnosis & Treatment pp. 86-98 (1988).
Hunt at at. The Surgical Wounq Dineen & Hildrick-Smith, eds., pp. 1-18 (1981).
International Search Report for PCT/US03127888, mailing date: Dec. 4, 2003.
International Search Report for PCT/USOI/27104. Mailed on Apr. 8, 2002.
Kannon and Garrett Dermatol. Burg. 21: 583590 (1995).
Kolodka, et al., “Evidence for Keratinocyte Stem Cells in vitro: Long Tenn Engraftment and Persistence of Transgene Expression from Retrovirus-Transduced Kerationocytes”, Proc. Natl. Acad. Sci. USA, 95:4356-4361(1998).
Kuroyanagi, et at., “A Cultured Skin Substitute Composed of castsand Kerationocytes with a Collagen Matrix: Preliminary Results of Clinical Trials”, Ann. Plait. Surg., 31:340-351 (1993).
Langdon, et at., “Reconstitution of Structure and Cell Function in Human Skin Grafts Derived from Cryopreserved Allogeneic Dennis and Autologous Cultured Keratinocytes”, J. Invest. Dermatol., 91:478-485 (1988).
Maruguchi, et at., “A New Skin Equivalent: Kerationocytes Proliferated and Differentiated on Collagen Sponge Containing Fibroblasts”, Plast. Reconstr. Surg., 93:537-546 (1994).
Richey et al., Annals of Plastic Surgery 23(2): 159-165 (1989).
Riley Am. Pam. Physician 24: 107-113 (1981).
Singer et al., “Cutaneous Wound Healing,”New England Journal of Medicine, 341:738-746, 1999.
Sugihara, et at., “Effects of Fat Cells on Keratinocytes and Fibroblasts in a Reconstructed Rat Skin Model Using Collagen Gel Matrix Culture”, British J. Dennatol., 144:244-253 (2001).
Winter Nature 193: 293.294 (1962).
Supplementary European Search Report issued in European Patent Application No. 03755791.5, dated Mar. 28, 2008.
Database WPI, “Artificial skin production-comprises cell cultivation of keratinocytes on base of gel of human fibrin populated with human fibroblasts,” Section Ch., Week 199940, Derwent Publications, Ltd., AN 1999-471189, 1999.
Database Prous Science Integrity (Online), “Modex advances Alox through early-stage clinical testing,” Database accession No. 323719, Aug. 7, 2002.

Affiliated with

Also associated with

Rating

Methods and compositions for tissue regeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for tissue regeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for tissue regeneration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4037380